Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Completed 6Withdrawn 3Unknown 3Recruiting 3Terminated 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Neoplasms 1Cardiovascular Abnormalities 1Cardiotoxicity 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Carvedilol × Clear all
NCT04939883 2024-06-28

CardioTox

Hospital Sirio-Libanes

Phase 4 Unknown
1,018 enrolled

Neoplasms, Cardiotoxicity

NCT02993198 2024-06-03

A Prospective Study of Breast Cancer Patients With Abnormal Strain Imaging

Northwestern University

Phase 2 Unknown
134 enrolled

Cardiovascular Abnormalities

NCT02944201 2021-02-21

Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate

Montefiore Medical Center

Phase 2 Unknown
22 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡